
Pediatric health in the U.S. shows alarming 17-year decline; GLP-1 meds still effective when interrupted; inequality, pollution and political instability accelerates aging – Morning Medical Update
Key Takeaways
- U.S. children's health has declined significantly since 2007, with increased mortality and chronic conditions compared to peers in high-income countries.
- GLP-1 medications, even with treatment interruptions, effectively aid weight loss when combined with lifestyle changes, as shown in a study of over 6,000 participants.
The top news stories in medicine today.
A new study in
Patients with inconsistent access to GLP-1 medications like semaglutide or tirzepatide still achieved
A sweeping study of over 160,000 people across 40 countries has found that poor air quality, social inequality and unstable political systems measurably speed up aging. Published in
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.




















